AI assistant
Sending…
AbbVie Inc. — Director's Dealing 2015
Feb 11, 2015
29755_dirs_2015-02-11_2ce9adb2-6bad-467a-9bc9-005346fc5b9c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2015-02-09
Reporting Person: SALEKI-GERHARDT AZITA (SVP, Operations)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-02-09 | Common stock, $0.01 par value | M | 2250 | $24.0731 | Acquired | 3168 | Indirect |
| 2015-02-09 | Common stock, $0.01 par value | F | 1425 | $56.90 | Disposed | 1743 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-02-09 | Option (right to buy) | $24.0731 | M | 2250 | Disposed | 2015-02-17 | Common stock (2250) | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common stock, $0.01 par value | 85828 | Direct |
| Common stock, $0.01 par value | 1738 | Indirect |
Footnotes
F1: Balance in the AbbVie Savings Program as of February 9, 2015.
F2: The reporting person disclaims beneficial ownership of all securities held by her spouse.
More from AbbVie Inc.
Regulatory Filings
2026
Jun 1
Declaration of Voting Results & Voting Rights Announcements
2026
May 12
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
Apr 29
Capital/Financing Update
2026
Apr 3
Major Shareholding Notification
2026
Mar 26
Proxy Solicitation & Information Statement
2026
Mar 23
Proxy Solicitation & Information Statement
2026
Mar 23
Capital/Financing Update
2026
Mar 4
Director's Dealing
2026
Mar 4